Epithelial Thickness Map

Sponsor
Vienna Institute for Research in Ocular Surgery (Other)
Overall Status
Recruiting
CT.gov ID
NCT04578184
Collaborator
(none)
50
1
2
4.5
11.1

Study Details

Study Description

Brief Summary

In keratoconic eyes, the corneal epithelium shows a localized thinning over the cone that is surrounded by an annulus of epithelial thickening. It has been postulated that epithelial thickness mapping can be a sensitive tool for the keratoconus diagnosis. In keratoconus screening the 5 mm diameter of the corneal centrum may be sufficient while studies have shown that the cone apex is located in this area.

Aim of this study is to assess agreement and repeatability of epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.

Secondary objective is to evaluate the differences between healthy and keratoconus eyes using epithelial thickness map data.

This is a prospective monocentric study that includes patients divided into two groups:

patients with keratoconus and a control group formed out of patients without corneal pathologies. For each patient only one eye will be included and corneal measurements will be performed, focused on the corneal epithelium thickness.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Corneal epithelial thickness measurements
N/A

Detailed Description

In total 50 eyes of 50 patients will be included, divided into two groups: study group comprised of 20 eyes with diagnosed keratoconus and a control group formed out of 30 healthy eyes.

Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation. After each measurement patients will be asked to blink in order to allow adequate tear-film recovery. Each patient will be measured three times with both devices. Only one visit will be necessary.

The order in which the measurements will be performed (Anterion or MS-39) will be randomised using randomised.org.

The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.

Main outcome variable:
  • Mean differences in central corneal epithelial thickness between the devices investigated (+ limits of agreement (1.96xSD) between the investigated devices)
Secondary outcome variables:
  • Repeatability coefficient (within subject standard deviation - SD) and coefficient of variation of the two devices

  • Comparison in epithelial thickness between normal and keratoconus eyes

  • Sensitivity and specificity of swept-source OCT device in keratoconus diagnosis

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comparison of Two Optical Coherence Tomography Devices in Corneal Epithelial Thickness Maps
Anticipated Study Start Date :
Oct 15, 2020
Anticipated Primary Completion Date :
Feb 1, 2021
Anticipated Study Completion Date :
Mar 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: Epithelial thickness map evaluation in keratoconus patients

Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation Each patient will be measured three times with both devices. The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.

Diagnostic Test: Corneal epithelial thickness measurements
Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.

Other: Epithelial thickness map evaluation in healthy cornea patients

Patients included in the study will be measured with the corneal acquisition mode, also allowing for epithelium thickness data, on each device without pupil dilatation Each patient will be measured three times with both devices. The corneal epithelial thickness will be measured as the distance between the air-tear and the epithelium-Bowman interfaces.

Diagnostic Test: Corneal epithelial thickness measurements
Corneal epithelial thickness measurements using two optical coherence tomography devices in healthy and keratoconus corneas.

Outcome Measures

Primary Outcome Measures

  1. Agreement between two ss-OCT devices in corneal epithelial thickness measurements (LoA in micrometer) [6 months]

Secondary Outcome Measures

  1. Repeatability between two ss-OCT devices in corneal epithelial thickness measurements (determination of within-subject standard deviation and Coefficient of variation) [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patient with diagnosed keratoconus (diagnosed using tomography and topography map changes and slit-lamp changes) and patients with healthy cornea

  • Age 21 and older

  • Signed informed consent

Exclusion Criteria:
  • Previous ocular surgery

  • Associated corneal pathologies (e.g. trauma, edema, scarring)

  • In women of childbearing age, a pregnancy test will be performed before inclusion into the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hanusch Hospital, Ophthalmology Department Vienna Austria 1140

Sponsors and Collaborators

  • Vienna Institute for Research in Ocular Surgery

Investigators

  • Principal Investigator: Oliver Findl, Prof., MD, Head of Department of Ophthalmology, Professor, Principal Investigator

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prim. Prof. Dr. Oliver Findl, MBA, Head of Department of Ophthalmology, Professor, Principal Investigator, MBA, Vienna Institute for Research in Ocular Surgery
ClinicalTrials.gov Identifier:
NCT04578184
Other Study ID Numbers:
  • Epithelial thickness map
First Posted:
Oct 8, 2020
Last Update Posted:
Oct 12, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2020